Skip to main content
NIH funding notice PAR-19-264

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)

Closed on December 10, 2021.

Posted
May 1, 2019
Close date
December 10, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,032,889 in first-year total cost, median $665,190.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 SBIB-S (59)]8
  2. Special Emphasis Panel[ZRG1 SBIB-A (59)]7
  3. Special Emphasis Panel[ZRG1 SBIB-E (59)]2

Most frequent institutions

  1. STANFORD UNIVERSITY2
  2. CASE WESTERN RESERVE UNIVERSITY1
  3. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  4. DUKE UNIVERSITY1
  5. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
Competing awards under PAR-19-264 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers1R01CA260399-01A1BARTON, JENNIFER KEHLETFISHMAN, DAVID A.LOKSHIN, ANNA E.UNIVERSITY OF ARIZONA, AZ$811,877ZRG1
2022Early Detection of Hepatocellular Carcinoma2R01CA195524-06A1BERETTA, LAURAFUENTES, DAVIDKOAY, EUGENE JUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$694,288ZRG1
2022Detecting and locating cancer for patients with CT-detected lung nodules1R01CA264864-01ZHOU, XIANGHONG JASMINEUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$665,190ZRG1
2022Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse1R01CA260259-01A1MARKOVIC, SVETOMIR NENADMAYO CLINIC ROCHESTER, MN$623,722ZRG1
2022Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI1R37CA260346-01A1RUSU, MIRABELASTANFORD UNIVERSITY, CA$573,475ZRG1
2022Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.1R37CA264798-01NAPPI, LUCIAPROVINCIAL HEALTH SERVICES AUTHORITY, BC$423,319ZRG1
2022Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications1R01CA271237-01GRIMM, LARS JRYSER, MARCDUKE UNIVERSITY, NC$403,142ZRG1
2021Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)1R01CA249992-01A1LEWIS, JAMESMADABHUSHI, ANANTCASE WESTERN RESERVE UNIVERSITY, OH$697,902ZRG1
2021Applying pathomics to establish a biosignature for aggressive skin melanoma.1R01CA260375-01CHANG, RUISAENGER, YVONNE MARGARETCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$693,456ZRG1
2021Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures1R01CA253923-01LANDMAN, BENNETT A.MALDONADO, FABIENVANDERBILT UNIVERSITY MEDICAL CENTER, TN$682,056ZRG1
2021Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease1R01CA249882-01A1LAVIOLETTE, PETER SMEDICAL COLLEGE OF WISCONSIN, WI$631,957ZRG1
2021Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease1R01CA253860-01A1CHANG, YOUNG HWANWONG, MELISSA H.OREGON HEALTH & SCIENCE UNIVERSITY, OR$629,276ZRG1
2021Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness1R01CA249909-01A1LARSON, PEDER ERIC ZUFALLWANG, ZHEN JANEUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$599,430ZRG1
2020Abbreviated MRI for HCC screening in cirrhotic patients1R01CA249765-01BASHIR, MUSTAFA R.REEDER, SCOTT B.SIRLIN, CLAUDE BTAOULI, BACHIRICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$947,520ZRG1
2020Pathomic Predictors of Prostate Cancer Progression1R01CA249899-01MALLICK, PARAG KUMARSTANFORD UNIVERSITY, CA$910,446ZRG1
2020Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer1R01CA249921-01THAKUR, MATHEW LAXMANTRABULSI, EDOUARD JOHNTHOMAS JEFFERSON UNIVERSITY, PA$700,603ZRG1
2020Early detection of colorectal cancer in the traditional and serrated pathways1R01CA249851-01WANG, THOMAS DUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$345,230ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) | ScienceDex | ConductScience